Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Srinivas

Showing results (131-140 of 935) with videos related to

Pageof 94
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics|March 16, 2011
The rationality for using prodrug approach in drug discovery programs for new xenobiotics: opportunities and challengesNuggehally R Srinivas
Biomedical Chromatography : BMC|April 6, 2011
Incurred sample reanalysis: dilemma in its applicability - should it be practiced for all bioanalytical assays involving single (parent or metabolite) or multiple analytes (parent/metabolite or parent with co-administered drugs)?Nuggehally R Srinivas
Biomedical Chromatography : BMC|April 30, 2009
Bioanalytical assay validation parameters re-visited: perspectives on stability studiesNuggehally R Srinivas
European Journal of Drug Metabolism and Pharmacokinetics|May 26, 2009
Rationale for faster oral delivery to overcome the pathophysiology associated with dental pain--biopharmaceutic and pharmacokinetic challengesNuggehally R Srinivas
European Journal of Clinical Pharmacology|February 28, 2012
Buccal and intranasal lorazepam clinical pharmacokinetics: can it adequately compete with intravenous lorazepam in pediatric care patients?Nuggehally R Srinivas
European Journal of Clinical Pharmacology|July 29, 2008
Dual drug interactions via P-glycoprotein (P-gp)/ cytochrome P450 (CYP3A4) interplay: recent case study of oral atorvastatin and verapamilNuggehally R Srinivas
Biomedical Chromatography : BMC|July 25, 2008
Assessment of bioequivalence of drug racemates: what are the cues from a bioanalytical perspective-stereoselective vs nonstereoselective?Nuggehally R Srinivas
European Journal of Drug Metabolism and Pharmacokinetics|April 24, 2015
Biochanin a: understanding the complexities in the paradoxical drug-drug interaction potentialNuggehally R Srinivas
Bioanalysis|November 19, 2010
First-in-human assays: excitement and introspectionNuggehally R Srinivas
Drug Metabolism and Pharmacokinetics|May 12, 2009
Pharmacokinetic screening strategy for discovery work-use of rodent species: lessons learnt and probing newer thoughtsNuggehally R Srinivas
Pageof 94

Showing results (131-140 of 935) with videos related to

Sort By:
Pageof 94
European Journal of Drug Metabolism and Pharmacokinetics|March 16, 2011
The rationality for using prodrug approach in drug discovery programs for new xenobiotics: opportunities and challengesNuggehally R Srinivas
Biomedical Chromatography : BMC|April 6, 2011
Incurred sample reanalysis: dilemma in its applicability - should it be practiced for all bioanalytical assays involving single (parent or metabolite) or multiple analytes (parent/metabolite or parent with co-administered drugs)?Nuggehally R Srinivas
Biomedical Chromatography : BMC|April 30, 2009
Bioanalytical assay validation parameters re-visited: perspectives on stability studiesNuggehally R Srinivas
European Journal of Drug Metabolism and Pharmacokinetics|May 26, 2009
Rationale for faster oral delivery to overcome the pathophysiology associated with dental pain--biopharmaceutic and pharmacokinetic challengesNuggehally R Srinivas
European Journal of Clinical Pharmacology|February 28, 2012
Buccal and intranasal lorazepam clinical pharmacokinetics: can it adequately compete with intravenous lorazepam in pediatric care patients?Nuggehally R Srinivas
European Journal of Clinical Pharmacology|July 29, 2008
Dual drug interactions via P-glycoprotein (P-gp)/ cytochrome P450 (CYP3A4) interplay: recent case study of oral atorvastatin and verapamilNuggehally R Srinivas
Biomedical Chromatography : BMC|July 25, 2008
Assessment of bioequivalence of drug racemates: what are the cues from a bioanalytical perspective-stereoselective vs nonstereoselective?Nuggehally R Srinivas
European Journal of Drug Metabolism and Pharmacokinetics|April 24, 2015
Biochanin a: understanding the complexities in the paradoxical drug-drug interaction potentialNuggehally R Srinivas
Bioanalysis|November 19, 2010
First-in-human assays: excitement and introspectionNuggehally R Srinivas
Drug Metabolism and Pharmacokinetics|May 12, 2009
Pharmacokinetic screening strategy for discovery work-use of rodent species: lessons learnt and probing newer thoughtsNuggehally R Srinivas
Pageof 94